Additionally, it is proposed that statins induce hepatic gluconeogenesis in human liver cells by activation of the pregnane X receptor (PXR) (121, 122), which could also counteract hypoglycemic conditions in CHI patients. The gene discussed is NR1I2; the disease is congenital isolated hyperinsulinism.